|
Volumn 64, Issue 6, 2009, Pages 1336-1338
|
In vitro activity of the new quinolone derivative RD-3 against clinical isolates of Mycoplasma pneumoniae and Mycoplasma hominis
a a |
Author keywords
Fluoroquinolones; MBCs; MICs
|
Indexed keywords
AZITHROMYCIN;
BIS(4,9,9A,10 TETRAHYDRO 9 PHENYL 3BH PYRROLIZINO[1,2 B]QUINOLIN 7) METHANE 12;
CLINDAMYCIN;
DOXYCYCLINE;
GATIFLOXACIN;
GEMIFLOXACIN;
MOXIFLOXACIN;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
TETRACYCLINE;
UNCLASSIFIED DRUG;
ANTIINFECTIVE AGENT;
QUINOLONE DERIVATIVE;
AGAR DILUTION;
ANTIBIOTIC RESISTANCE;
BACTERIAL STRAIN;
BACTERICIDAL ACTIVITY;
BACTERIUM CULTURE;
BACTERIUM ISOLATE;
COLONY FORMATION;
CULTURE MEDIUM;
DRUG STRUCTURE;
DRUG SYNTHESIS;
IN VITRO STUDY;
LETTER;
MINIMUM INHIBITORY CONCENTRATION;
MYCOPLASMA HOMINIS;
MYCOPLASMA PNEUMONIAE;
NONHUMAN;
STRUCTURE ANALYSIS;
ARTICLE;
CHEMICAL STRUCTURE;
CHEMISTRY;
DRUG EFFECT;
HUMAN;
ISOLATION AND PURIFICATION;
MICROBIOLOGICAL EXAMINATION;
MICROBIOLOGY;
MYCOPLASMOSIS;
ANTI-BACTERIAL AGENTS;
HUMANS;
MICROBIAL SENSITIVITY TESTS;
MOLECULAR STRUCTURE;
MYCOPLASMA HOMINIS;
MYCOPLASMA INFECTIONS;
MYCOPLASMA PNEUMONIAE;
QUINOLONES;
|
EID: 76249113523
PISSN: 03057453
EISSN: 14602091
Source Type: Journal
DOI: 10.1093/jac/dkp375 Document Type: Letter |
Times cited : (5)
|
References (6)
|